EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity

Knut Brockow; Michael R. Ardern-Jones; Maja Mockenhaupt; Werner Aberer; Annick Barbaud; Jean Christoph Caubet; Radoslaw Spiewak; María José Torres; Charlotte G. Mortz

doi:10.1111/all.13562

EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity

Knut Brockow
, Michael R. Ardern-Jones
, Maja Mockenhaupt
, Werner Aberer
, Annick Barbaud
, Jean Christoph Caubet
, Radoslaw Spiewak
, María José Torres
, Charlotte G. Mortz

Research output: Contribution to journal › Article › peer-review

201 Scopus citations

Abstract

Drug hypersensitivity reactions (DHRs) are common, and the skin is by far the most frequently involved organ with a broad spectrum of reaction types. The diagnosis of cutaneous DHRs (CDHR) may be difficult because of multiple differential diagnoses. A correct classification is important for the correct diagnosis and management. With these guidelines, we aim to give precise definitions and provide the background needed for doctors to correctly classify CDHR.

Original language	English
Pages (from-to)	14-27
Number of pages	14
Journal	Allergy: European Journal of Allergy and Clinical Immunology
Volume	74
Issue number	1
DOIs	https://doi.org/10.1111/all.13562
State	Published - Jan 2019
Externally published	Yes

Access to Document

10.1111/all.13562

Cite this

@article{e3f9d72cd18643a98a51a1d48a8e478b,

title = "EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity",

abstract = "Drug hypersensitivity reactions (DHRs) are common, and the skin is by far the most frequently involved organ with a broad spectrum of reaction types. The diagnosis of cutaneous DHRs (CDHR) may be difficult because of multiple differential diagnoses. A correct classification is important for the correct diagnosis and management. With these guidelines, we aim to give precise definitions and provide the background needed for doctors to correctly classify CDHR.",

author = "Knut Brockow and Ardern-Jones, \{Michael R.\} and Maja Mockenhaupt and Werner Aberer and Annick Barbaud and Caubet, \{Jean Christoph\} and Radoslaw Spiewak and Torres, \{Mar{\'i}a Jos{\'e}\} and Mortz, \{Charlotte G.\}",

note = "Publisher Copyright: {\textcopyright} 2018 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.",

year = "2019",

month = jan,

doi = "10.1111/all.13562",

language = "English",

volume = "74",

pages = "14--27",

journal = "Allergy: European Journal of Allergy and Clinical Immunology",

issn = "0105-4538",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "1",

}

TY - JOUR

T1 - EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity

AU - Brockow, Knut

AU - Ardern-Jones, Michael R.

AU - Mockenhaupt, Maja

AU - Aberer, Werner

AU - Barbaud, Annick

AU - Caubet, Jean Christoph

AU - Spiewak, Radoslaw

AU - Torres, María José

AU - Mortz, Charlotte G.

PY - 2019/1

Y1 - 2019/1

N2 - Drug hypersensitivity reactions (DHRs) are common, and the skin is by far the most frequently involved organ with a broad spectrum of reaction types. The diagnosis of cutaneous DHRs (CDHR) may be difficult because of multiple differential diagnoses. A correct classification is important for the correct diagnosis and management. With these guidelines, we aim to give precise definitions and provide the background needed for doctors to correctly classify CDHR.

AB - Drug hypersensitivity reactions (DHRs) are common, and the skin is by far the most frequently involved organ with a broad spectrum of reaction types. The diagnosis of cutaneous DHRs (CDHR) may be difficult because of multiple differential diagnoses. A correct classification is important for the correct diagnosis and management. With these guidelines, we aim to give precise definitions and provide the background needed for doctors to correctly classify CDHR.

UR - https://www.scopus.com/pages/publications/85053730094

U2 - 10.1111/all.13562

DO - 10.1111/all.13562

M3 - Article

C2 - 30028512

AN - SCOPUS:85053730094

SN - 0105-4538

VL - 74

SP - 14

EP - 27

JO - Allergy: European Journal of Allergy and Clinical Immunology

JF - Allergy: European Journal of Allergy and Clinical Immunology

IS - 1

ER -

EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity

Abstract

Access to Document

Fingerprint

Cite this